Aceragen, Inc. (ACGN) vs Palatin Technologies, Inc. (PTN)
Aceragen, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Aceragen, Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.1M). Aceragen, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Aceragen, Inc. grew revenue faster over the last twelve months: 1,226.3% against 86.5%. Palatin Technologies, Inc. has the higher net margin (−47.2% vs −467.5%) and the lower return on invested capital (−942.3% vs −135.4%). Across the 17 metrics below, Palatin Technologies, Inc. leads on 11 and Aceragen, Inc. on 6.
Valuation
Profitability
| Metric | ACGN | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 83.46% | 100.00% | 65.16% |
| Operating margin | (503.92%) | (49.26%) | 0.00% |
| Net margin | (467.53%) | (47.22%) | 0.00% |
| Free cash flow margin | (339.17%) | (113.25%) | 0.00% |
| Return on equity | (169.66%) | (297.25%) | (57.72%) |
| Return on assets | (75.58%) | (73.72%) | (49.22%) |
| Return on invested capital | (135.35%) | (942.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack